Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Unspecified Childhood Solid Tumor, Protocol Specific: early-phase trial registry
1 of 15 indexed Unspecified Childhood Solid Tumor, Protocol Specific trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,140 of 28,707 conditions by registered trial count.
15 US clinical trials · 1 currently recruiting · #1,140 of 28,707 conditions by registered trial count
Unspecified Childhood Solid Tumor, Protocol Specific: 15 US clinical trials tracked, 1 recruiting.
Unspecified Childhood Solid Tumor, Protocol Specific is the subject of 15 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Oncology Group, running 5 of these trials.
Enrollment posture brief
Registry condition unspecified-childhood-solid-tumor-protocol-specific
OPEN 1 | RECR 7% | LATE 1 | EARLY 9 | RANK #1140 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Liver Disease (7% recruiting · 15 trials)
Unspecified Childhood Solid Tumor, Protocol Specific lists 1 open slots (7% of 15 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Unspecified Childhood Solid Tumor, Protocol Specific on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Unspecified Childhood Solid Tumor, Protocol Specific is recruiting below its size-band peers.
1 of 15 indexed trials (6.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Unspecified Childhood Solid Tumor, Protocol Specific research.
Children's Oncology Group accounts for 5 of 15 trials (33.3%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Unspecified Childhood Solid Tumor, Protocol Specific enrolment sits around 49 participants.
Median target enrolment is 49 among the 14 trials that report a genuine target (sentinel values excluded). 8 of those (57.1%) plan for fewer than 100 participants.
-
Unspecified Childhood Solid Tumor, Protocol Specific research is mostly interventional.
13 interventional and 2 observational studies make up this index (86.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
15 total, page 1 of 1
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Wake Forest University Health Sciences
NCT00900471
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Roswell Park Cancer Institute
NCT00003816
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
Children's Oncology Group
NCT00458887
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
University of South Florida
NCT01346267
Pharmacokinetics of Daunorubicin in Young Patients With Cancer
Children's Oncology Group
NCT00673257
Telephone-Based Cancer Education With or Without Telephone-Based Counseling in Young Participants
Georgetown University
NCT00459238
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Children's Oncology Group
NCT01164163
Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment
National Cancer Institute (NCI)
NCT00880282
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
National Cancer Institute (NCI)
NCT00079404
Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
National Cancer Institute (NCI)
NCT00004919
Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors
University of California, Davis
NCT00389584
Bevacizumab in Treating Young Patients With Refractory Solid Tumors
National Cancer Institute (NCI)
NCT00085111
Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer
Children's Oncology Group
NCT00003070
Interferon Alfa in Treating Children With HIV-Related Cancer
Children's Oncology Group
NCT00002621
Irinotecan in Treating Children With Refractory or Progressive Solid Tumors
Texas Children's Cancer Center
NCT00016861
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Unspecified Childhood Solid Tumor, Protocol Specific records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Unspecified Childhood Solid Tumor, Protocol Specific trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Unspecified Childhood Solid Tumor, Protocol Specific page
15 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Unspecified Childhood Solid Tumor, Protocol Specific trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Children's Oncology Group sponsors the most Unspecified Childhood Solid Tumor, Protocol Specific trials on record, review their full trial history before evaluating a specific study. See Children's Oncology Group's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Unspecified Childhood Solid Tumor, Protocol Specific condition card totals 15 registered trials; most-linked intervention pharmacological study; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.